| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6116862 | Human Immunology | 2013 | 4 Pages |
Abstract
The glucose-lowering rate in T2DM+CHD group should be no more than 4 mmol Lâ1 dâ1 and the appropriate glucose-lowering rate in T2DM group is no more than 6 mmol Lâ1 dâ1. Serum levels of cTnI and hs-CRP will be increased if the glucose-lowering rate is over this range, which means that cardiovascular endpoints might be induced.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Weihua Wu, Qian Li, Jing Xia, Mingli Wang, Zhenjie Sun, Jiajing Miao, Zhaohui Zheng,